Home
NewsNewsIran Health Agency Expands Fertility Treatment Services to meet rising global demand, offering advanced testing, IVF, expert consultation, and full post-treatment follow-up. The program also includes visa assistance, travel coordination, accommodation support, and multilingual guidance, ensuring international patients receive structured, end-to-end reproductive care in Iran.
A leading medical tourism facilitator in Iran, Iran Health Agency Expands Fertility Treatment options for international patients in an announcement. These services would have in them advanced evaluation, specialized consultation, and IVF treatments, along with comprehensive post-treatment follow-up.
It is worth noting that the agency coordinates care by way of assisting patients all across the treatment process, right from those initial inquiries and appointment scheduling to post-treatment communication along with the medical providers.
Due to a growing global demand when it comes to high-quality and dependable fertility care, the Iran Health Agency now provides fertility treatment options like a comprehensive range of fertility services, which includes consultation with experts, advanced testing for couples, IVF as well as other assisted reproductive technologies, and of course complete support all throughout the medical journey. These services are crafted to ensure a safe, comfortable, as well as a successful experience as far as international patients traveling to Iran are concerned, especially in the gamut of fertility treatment.
As per the spokesperson from the agency, their mission is to ensure that every step of the fertility treatment journey for international patients is clear, safe, and without any hassles. Through offering complete support right from initial consultation to post-treatment follow-up, patients are going to get the best possible opportunity to attain their family planning targets.
Iran Health Agency now offers a range of services that include the likes of -
Besides the Iran Health Agency Expands Fertility Treatment and offering medical services, the agency also rolls out assistance for visas, travel coordination, accommodation, and airport transfers, as well as 24/7 multilingual support to make sure that the patients complete their treatment journey in a very efficient way, with immense peace of mind.
Luna and Kindbody are redefining Intelligence in Fertility Care through a strategic partnership that integrates wearable biomarker tracking into clinical pathways. By capturing real-time physiological data, the collaboration enables personalised insights, enhances decision-making, and creates a more connected, data-driven fertility journey for patients and care providers alike.
Sapyen and Avenues launch at-home fertility diagnostics, introducing a couple-first testing model in the UK. By integrating semen analysis and AMH testing into early care, this approach reduces clinic visits, accelerates diagnosis, and ensures balanced fertility evaluation, transforming how patients begin their reproductive health journey.
Nexpring Health has invested in May Health to accelerate the development of the Anavi™ System, a novel device designed to treat PCOS-Related Infertility. The technology aims to restore ovulation through a single office-based procedure, expanding treatment options for millions of women affected by polycystic ovary syndrome.
INVO Fertility would be introducing time-lapse incubation technology at its Wisconsin clinic, hence offering high-quality lab care, creative patient solutions, and advanced embryo monitoring for improved fertility results.
Costco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.
Carea has launched its Trying to Conceive - IVF/IUI mode to help women undergoing intricate fertility treatment with risks of inconsistent clinic continuity through continuous tracking and expert guidance.
The Minnesota bill for infertility treatments mandates comprehensive insurance coverage for diagnosis, IVF, and fertility preservation across public and private health plans. Set for implementation in 2027, the legislation expands access, modernises infertility definitions, and ensures cost-sharing protections to make reproductive healthcare more equitable.
